Johnson & Johnson(JNJ.US)

Event Tracking

Dec30

Barclays Maintains Hold Rating on Johnson & Johnson

07:46

Dec29

Johnson & Johnson Completes Acquisition of Halda Therapeutics for $3.05B

13:00

Dec27

Baogang Wealth Management Reduces Johnson & Johnson Shares

08:04

Dec26

Johnson & Johnson's JNJ-95475939 for Atopic Dermatitis Fails to Meet Efficacy Standards in Phase 2b Trial

15:06

Johnson & Johnson's JNJ-5939 Shows Good Tolerance in 2B Phase DUPLEX-AD Study and Meets Criteria for Early Termination

13:09

Johnson & Johnson Pauses JNJ-5939 Clinical Trial

13:01

Schedules & Filings

Schedules

Filings

Jan21

Earning Release(EST)

FY2025 Q4 Earning Release

Dec9

Distribution Plan(EST)

Cash dividend 1.3 USD

Nov25

Distribution Plan(EST)

Cash dividend 1.3 USD

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change